TY - JOUR
T1 - Induktion von knochengewebe auf unterschiedlichen matrizes
T2 - Eine in-vitro- und in-vivo-pilotstudie in der SCID maus
AU - Kasten, P.
AU - Luginbühl, R.
AU - Vogel, J.
AU - Niemeyer, P.
AU - Weiss, S.
AU - Van Griensven, M.
AU - Krettek, C.
AU - Bohner, M.
AU - Bosch, U.
AU - Tonak, M.
PY - 2004/7
Y1 - 2004/7
N2 - Aim: Three resorbable biomaterials were evaluated regarding proliferation and osteogenic differentiation of human bone marrow stromal cells (BMSC) in vitro. In a second step, the new biomaterial, calcium-deficient hydroxyapatite (CDHA), was tested in a pilot in vivo study by subcutaneous implantation in the severe combined immunodeficiency (SCID) mouse. Methods: CDHA, β-tricalcium phosphate (β-TCP), and demineralized bone matrix (DBM) were seeded with human BMSC and cultured in osteogenic supplements for 3 weeks. In the pilot in vivo study, CDHA was seeded with BMSC and kept in osteogenic media for 2 weeks (group A) before subcutaneous implantation in 8 SCID mice for 3 and 8 weeks. In addition, CDHA seeded with BMSC without prior osteogenic induction (group B) and empty ceramics were implanted in each mouse. Results: Total protein content and the values for specific alkaline phosphatase (ALP) increased significantly in vitro on all matrices, but no significant difference between the groups was noted. In the pilot in vivo study all ceramics were well penetrated by cells. After 8 weeks 2 of 4 samples in group B and 1 of 4 samples in group A revealed cells resembling hypertrophic chondrocytes. Specific ALP was higher in the group B (p = 0.012, Z = -2.5) compared to empty ceramics. There were no significant differences between groups A and B. Differences between group A and the empty control did not become significant (p = 0.069, Z = -1.8). Conclusion: All three matrices promoted BMSC proliferation and differentiation to osteogenic cells in vitro. Human BMSC on CDHA showed signs of osteogenic differentiation after subcutaneous implantation into SCID mice.
AB - Aim: Three resorbable biomaterials were evaluated regarding proliferation and osteogenic differentiation of human bone marrow stromal cells (BMSC) in vitro. In a second step, the new biomaterial, calcium-deficient hydroxyapatite (CDHA), was tested in a pilot in vivo study by subcutaneous implantation in the severe combined immunodeficiency (SCID) mouse. Methods: CDHA, β-tricalcium phosphate (β-TCP), and demineralized bone matrix (DBM) were seeded with human BMSC and cultured in osteogenic supplements for 3 weeks. In the pilot in vivo study, CDHA was seeded with BMSC and kept in osteogenic media for 2 weeks (group A) before subcutaneous implantation in 8 SCID mice for 3 and 8 weeks. In addition, CDHA seeded with BMSC without prior osteogenic induction (group B) and empty ceramics were implanted in each mouse. Results: Total protein content and the values for specific alkaline phosphatase (ALP) increased significantly in vitro on all matrices, but no significant difference between the groups was noted. In the pilot in vivo study all ceramics were well penetrated by cells. After 8 weeks 2 of 4 samples in group B and 1 of 4 samples in group A revealed cells resembling hypertrophic chondrocytes. Specific ALP was higher in the group B (p = 0.012, Z = -2.5) compared to empty ceramics. There were no significant differences between groups A and B. Differences between group A and the empty control did not become significant (p = 0.069, Z = -1.8). Conclusion: All three matrices promoted BMSC proliferation and differentiation to osteogenic cells in vitro. Human BMSC on CDHA showed signs of osteogenic differentiation after subcutaneous implantation into SCID mice.
KW - Biomaterials
KW - Bone marrow stromal cells
KW - Bone tissue engineering
KW - Ceramics
KW - SCID mice
UR - http://www.scopus.com/inward/record.url?scp=4544256924&partnerID=8YFLogxK
U2 - 10.1055/s-2004-820342
DO - 10.1055/s-2004-820342
M3 - Artikel
C2 - 15346310
AN - SCOPUS:4544256924
SN - 0044-3220
VL - 142
SP - 467
EP - 475
JO - Zeitschrift fur Orthopadie und Ihre Grenzgebiete
JF - Zeitschrift fur Orthopadie und Ihre Grenzgebiete
IS - 4
ER -